Head of Scientific
Dr. Aloke Dutta completed a MS degree in chemistry from Calcutta University and a Ph.D. from the Dept. of Chemistry at Ohio University. He completed a postdoctoral fellowship at the Department of Radiology/Medicinal Chemistry at Univ. of Minnesota where he was involved in research and development of potential biomarkers for Parkinson’s and Alzheimer’s Diseases. In 1993 he joined Organix, Inc as a research scientist and shortly thereafter was awarded his first independent young investigator NIH grant award in the CNS drug development area. In 1998, Dr. Dutta moved to Wayne State University in the Department of Pharmaceutical Sciences and was promoted to full professor in 2005. Dr. Dutta’s research interest is in the CNS disorder area including Depression, drug abuse, and Parkinson’s disease.
Dr. Dutta has received multiple NIH R01 grants as a Principal Investigator (PI) with a research focus on neurodegeneration and major depressive disorder. Over the years, he was awarded 9 NIH grants totaling greater than $10 million dollars for his research projects and has received support from NIDA/NIH, NINDS/NIH, and NIMH/NIH. He was awarded an outstanding research achievement award in 2011 by the Eugene Applebaum College of Pharmacy and Health Sciences. Dr. Dutta has authored 99 publications and 12 patents. His work in the area of depression and related disorders has led to synthesis and characterization of novel pyran-based molecules which have the pharmacology of triple reuptake inhibitors. Several of the compounds from the pyran series are now being developed for therapeutic indications including MDD, PTSD and ADHD.
Aloke Dutta, PhD